LRPAP1 and Alzheimer disease: Together with the evidence from both in vitro and in vivo animal studies, our observation that RAP is reduced in the AD brain and is significantly associated with increased Aβ pathology suggests that RAP plays an important role in the accumulation and aggregation of Aβ in AD, possibly via an LRP1‐independent mechanism.